Cargando…

Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada

OBJECTIVES: Whether warfarin-treated patients with non-valvular atrial fibrillation (NVAF) who exhibit good control will experience deterioration in control over time is uncertain. We designed this study to examine the time in therapeutic range (TTR) in a population-based cohort of patients with NVA...

Descripción completa

Detalles Bibliográficos
Autores principales:	McAlister, Finlay A, Wiebe, Natasha, Hemmelgarn, Brenda R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829778/ https://www.ncbi.nlm.nih.gov/pubmed/29382672 http://dx.doi.org/10.1136/bmjopen-2017-016980

Ejemplares similares

The COVID-19 pandemic did not negatively impact frequency or continuity of outpatient care in Alberta, Canada
por: McAlister, Finlay A., et al.
Publicado: (2023)

Characteristics of Adults With Type 2 Diabetes Mellitus by Category of Chronic Kidney Disease and Presence of Cardiovascular Disease in Alberta Canada: A Cross-Sectional Study
por: Tonelli, Marcello, et al.
Publicado: (2019)

Follow-up Care of Living Kidney Donors in Alberta, Canada
por: Lam, Ngan N., et al.
Publicado: (2018)

Which Adults Presenting for Severe Acute Respiratory Syndrome Coronavirus 2 Testing Are Most Likely to Produce a Positive Swab Result?: A Population-Based Cohort of 15,132 Adults From Alberta, Canada
por: McAlister, Finlay A., et al.
Publicado: (2021)

Trends in the Management of Patients With Kidney Failure in Alberta, Canada (2004-2013)
por: Chong, Christy C., et al.
Publicado: (2017)

Age modification of diabetes-related hospitalization among First Nations adults in Alberta, Canada
por: Campbell, David JT, et al.
Publicado: (2014)

Yield of routine staging laparoscopy in patients with gastric cancer in Alberta, Canada
por: Nostedt, Jordan J., et al.
Publicado: (2022)

Association of vitamin D status with socio-demographic factors in Calgary, Alberta: an ecological study using Census Canada data
por: Naugler, Christopher, et al.
Publicado: (2013)

Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta
por: King, James A., et al.
Publicado: (2021)

Symptômes associés au frottis SRAS-CoV-2-positif chez des enfants de l’Alberta
por: King, James A., et al.
Publicado: (2021)

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Identifying subgroups of adult high-cost health care users: a retrospective analysis
por: Wick, James, et al.
Publicado: (2022)

Overview of the Alberta Kidney Disease Network
por: Hemmelgarn, Brenda R, et al.
Publicado: (2009)

Age, multimorbidity and dementia with health care costs in older people in Alberta: a population-based retrospective cohort study
por: Tonelli, Marcello, et al.
Publicado: (2022)

Dataset of clinical laboratory tests according to ordering variance among family physicians in Calgary, Alberta, Canada
por: Nguyen, Leonard T., et al.
Publicado: (2019)

Mortality and Resource Use Among Individuals With Chronic Kidney Disease or Cancer in Alberta, Canada, 2004-2015
por: Tonelli, Marcello, et al.
Publicado: (2022)

Outcomes Among Patients Hospitalized With Non–COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada
por: McAlister, Finlay A., et al.
Publicado: (2023)

Understanding challenges of using routinely collected health data to address clinical care gaps: a case study in Alberta, Canada
por: McGuckin, Taylor, et al.
Publicado: (2022)

Barriers experienced by families new to Alberta, Canada when accessing routine-childhood vaccinations
por: Fullerton, Madison M., et al.
Publicado: (2023)

The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study
por: McAlister, Finlay A., et al.
Publicado: (2022)

Comparative Risk of Harm Associated with Zopiclone or Trazodone Use in Nursing Home Residents: a Retrospective Cohort Study in Alberta, Canada
por: Watt, Jennifer A., et al.
Publicado: (2023)

Variability in the Calculation of Time in Therapeutic Range for the Quality Control Measurement of Warfarin
por: Siddiqui, Safia, et al.
Publicado: (2018)

Identification of environmental and genetic factors that influence warfarin time in therapeutic range
por: Botton, Mariana R., et al.
Publicado: (2020)

Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic
por: Lee, Siew Ling, et al.
Publicado: (2021)

Informing COVID-19 vaccination priorities based on the prevalence of risk factors among adults in Canada
por: McAlister, Finlay A., et al.
Publicado: (2021)

Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant Data
por: Kuang, Yun, et al.
Publicado: (2022)

Frequent users of emergency departments and patient flow in Alberta and Ontario, Canada: an administrative data study
por: Chen, Anqi, et al.
Publicado: (2020)

Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2016)

Changes in ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic in Alberta: a population study
por: Ganesh, Aravind, et al.
Publicado: (2022)

Changes in mammography screening in Ontario and Alberta following national guideline dissemination: an interrupted time series analysis
por: Fahim, Christine, et al.
Publicado: (2022)

Sociodemographic correlates of 25-hydroxyvitamin D test utilization in Calgary, Alberta
por: de Koning, Lawrence, et al.
Publicado: (2014)

Influence of Using Different Databases and ‘Look Back’ Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers
por: Chen, Guanmin, et al.
Publicado: (2016)

A prospective evaluation of the established criteria for heart failure with preserved ejection fraction using the Alberta HEART cohort
por: Ezekowitz, Justin A., et al.
Publicado: (2017)

Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry
por: Tran, Dat T., et al.
Publicado: (2019)

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
por: Kılıç, Salih, et al.
Publicado: (2017)

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
por: Udell, Jacob A., et al.
Publicado: (2022)

Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
por: Rymkiewicz, Peter, et al.
Publicado: (2016)

Is it time to reconsider ring vaccination for COVID-19?
por: McAlister, Vivian C.
Publicado: (2022)

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2018)

Quality Improvement Program Improves Time in Therapeutic Range for Hemodialysis Recipients Taking Warfarin
por: Blum, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vq25rlqrnm8147enp908vi2125